| CaMKII is a RIP3 substrate mediating ischemia-and oxidative stress–induced myocardial necroptosis T Zhang, Y Zhang, M Cui, LI Jin, Y Wang, F Lv, Y Liu, W Zheng, H Shang, ... Nature medicine 22 (2), 175-182, 2016 | 749 | 2016 |
| Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders R Song, W Peng, Y Zhang, F Lv, HK Wu, J Guo, Y Cao, Y Pi, X Zhang, ... Nature 494 (7437), 375-379, 2013 | 312 | 2013 |
| Hominoid-Specific De Novo Protein-Coding Genes Originating from Long Non-Coding RNAs C Xie, YE Zhang, JY Chen, CJ Liu, WZ Zhou, Y Li, M Zhang, R Zhang, ... Public Library of Science 8 (9), e1002942, 2012 | 175 | 2012 |
| Targeting CaMKII-δ9 ameliorates cardiac ischemia/reperfusion injury by inhibiting myocardial inflammation Y Yao, F Li, M Zhang, L Jin, P Xie, D Liu, J Zhang, X Hu, F Lv, H Shang, ... Circulation Research 130 (6), 887-903, 2022 | 72 | 2022 |
| Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond J Zhang, D Liu, M Zhang, Y Zhang British journal of pharmacology 176 (22), 4319-4339, 2019 | 68 | 2019 |
| Novel CaMKII-δ inhibitor hesperadin exerts dual functions to ameliorate cardiac ischemia/reperfusion injury and inhibit tumor growth J Zhang, R Liang, K Wang, W Zhang, M Zhang, L Jin, P Xie, W Zheng, ... Circulation 145 (15), 1154-1168, 2022 | 57 | 2022 |
| CaMKII-δ9 promotes cardiomyopathy through disrupting UBE2T-dependent DNA repair M Zhang, H Gao, D Liu, X Zhong, X Shi, P Yu, L Jin, Y Liu, Y Tang, Y Song, ... Nature cell biology 21 (9), 1152-1163, 2019 | 48 | 2019 |
| Cardiac Ischemic Preconditioning Promotes MG53 Secretion Through H2O2-Activated Protein Kinase C-δ Signaling D Shan, S Guo, HK Wu, F Lv, L Jin, M Zhang, P Xie, Y Wang, Y Song, ... Circulation 142 (11), 1077-1091, 2020 | 46 | 2020 |
| β-arrestin 2 mediates cardiac ischemia-reperfusion injury via inhibiting GPCR-independent cell survival signalling Y Wang, L Jin, Y Song, M Zhang, D Shan, Y Liu, M Fang, F Lv, RP Xiao, ... Cardiovascular research 113 (13), 1615-1626, 2017 | 37 | 2017 |
| Statins improve endothelial function via suppression of epigenetic-driven EndMT C Liu, M Shen, WLW Tan, IY Chen, Y Liu, X Yu, H Yang, A Zhang, Y Liu, ... Nature cardiovascular research 2 (5), 467-485, 2023 | 33 | 2023 |
| Glycolytic reprogramming in macrophages and MSCs during inflammation X Li, H Shen, M Zhang, V Teissier, EE Huang, Q Gao, M Tsubosaka, ... Frontiers in Immunology 14, 1199751, 2023 | 19 | 2023 |
| Protocol to measure contraction, calcium, and action potential in human-induced pluripotent stem cell-derived cardiomyocytes JZ Zhang, SR Zhao, C Tu, P Pang, M Zhang, JC Wu STAR protocols 2 (4), 100859, 2021 | 19 | 2021 |
| Human induced pluripotent stem cells as a screening platform for drug-induced vascular toxicity C Tu, NJ Cunningham, M Zhang, JC Wu Frontiers in Pharmacology 12, 613837, 2021 | 13 | 2021 |
| The role of metabolism in directed differentiation versus trans-differentiation of cardiomyocytes JWS Jahng, M Zhang, JC Wu Seminars in cell & developmental biology 122, 56-65, 2022 | 9 | 2022 |
| CaMKII-δ9 induces cardiomyocyte death to promote cardiomyopathy and heart failure M Zhang, J Zhang, W Zhang, Q Hu, L Jin, P Xie, W Zheng, H Shang, ... Frontiers in Cardiovascular Medicine 8, 820416, 2022 | 9 | 2022 |
| Deconvoluting the cells of the human heart with iPSC technology: Cell types, protocols, and uses B Yu, SR Zhao, CD Yan, M Zhang, JC Wu Current Cardiology Reports 24 (5), 487-496, 2022 | 7 | 2022 |
| Yixin‐Shu capsules ameliorated ischemia‐induced heart failure by restoring Trx2 and inhibiting JNK/p38 activation C Xiang, F Zhang, J Gao, F Guo, M Zhang, R Zhou, J Wei, P Wang, ... Oxidative Medicine and Cellular Longevity 2021 (1), 8049079, 2021 | 5 | 2021 |
| CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity C Liu, M Shen, Y Liu, A Manhas, SR Zhao, M Zhang, N Belbachir, L Ren, ... Cell Stem Cell 31 (12), 1760-1776. e9, 2024 | 1 | 2024 |
| Nutrition and metabolism in musculoskeletal disorders M Zhang, B Shan, S Lin, J Xu, N Zhang Frontiers in Nutrition 10, 1269939, 2023 | 1 | 2023 |
| CaMKII: Therapeutic target in vascular diseases warranted for Clinical and Translational Discovery? M Zhang, CK Lam Clinical and Translational Discovery 2 (3), 2022 | 1 | 2022 |
Hua GaoStanford UniversityDirección de correo verificada de stanford.edu